The new news in stem cell research
DEC 1, 2017 – PRESENTATION Empowerment Day 2017 – Parkinson’s Association of San Diego, San Diego, CA, USA
Aspen Neuroscience does not make determination on patient eligibility for clinical trials and all trial related enrollment and eligibility decisions are made by clinical trial sites under the direction of a Principal Investigator. ANPD001 is investigational and is not yet approved by the FDA. At this time, Aspen Neuroscience does not offer or participate in compassionate use or expanded access programs for ANPD001.